Previous close | 0.1535 |
Open | 0.1600 |
Bid | 0.2250 x 2200 |
Ask | 0.1543 x 300 |
Day's range | 0.1314 - 0.1850 |
52-week range | 0.0850 - 3.5900 |
Volume | |
Avg. volume | 2,116,034 |
Market cap | 7.615M |
Beta (5Y monthly) | 2.23 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The recent 19% drop in Galera Therapeutics, Inc.'s ( NASDAQ:GRTX ) stock could come as a blow to insiders who purchased...
Galera Therapeutics, Inc. (GRTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Regulatory updates from SAGE and Galera (GRTX) are in focus in the biotech sector.